ARMEOS
ActiveSummary
ARMEOS has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €14.5m and a net result of €3.0m. Equity is shrinking by about 3.1% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.1% (very low).
Group and network
Holdings and subsidiaries
1 holding · 4 subsidiaries in the treeHoldings 1
-
75.01%
All subsidiaries, including indirect ones 4
Companies in which this company or one of its subsidiaries holds more than half, or which it consolidates according to the LEI register.
EURVEST 75.01%3 subsidiaries
- Laboratoire des Produits Hyodall SIRET 31484406900026FR 100%
- NICOLS INTERNATIONAL 100%
- Nicols Poland Spolka z.o.o.PL 100%
According to the 2025 annual accounts of ARMEOS and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
No directors read yet: 2 of 12 Gazette acts processed.